Prostatic cryptococcal infection
King, C.; Finley, R.; Chapman, S.W.
Annals of Internal Medicine 113(9): 720
1990
ISSN/ISBN: 0003-4819 PMID: 2221655 Document Number: 365247
A case is reported in a 48-yr-old man with recurrent Cryptococcus neoformans infection from a prostatic source. Initial amphotericin B therapy was replaced with oral fluconazole (200 mg/d) to be given for 6 months.
Document emailed within 1 workday
Related Documents
Subramanian, S.; Mathai, D. 2005: Clinical manifestations and management of cryptococcal infection Journal of Postgraduate Medicine 51(Suppl 1): S21-S26Benes, Z.; Koten, J.; Kabelková, M.; Benes, J. 2006: Imported cryptococcal infection mimicking primary sclerosing cholangitis Klinicka Mikrobiologie a Infekcni Lekarstvi 12(6): 240-243
Roig, P.; Carrasco, R.; Salavert, M.; Nieto, A.; Bernacer, B.; Rodríguez, M.; Navarro, V. 1992: Fluconazole treatment of cryptococcal meningitis associated with HIV infection. Presentation of 4 cases Revista Clinica Espanola 190(3): 125-127
Chongkolwatana, C.; Suwanagool, P.; Suwanagool, S.; Thongyai, K.; Chongvisal, S.; Metheetrirut, C. 1998: Primary cryptococcal infection of the larynx in a patient with AIDS: a case report Journal of the Medical Association of Thailand 81(6): 462-467
True, D.G.; Penmetcha, M.; Peckham, S.J. 2002: Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab Journal of Rheumatology 29(7): 1561-1563
Nosanchuk, J.D.; Mednick, A.; Shi, L.; Casadevall, A. 2003: Experimental murine cryptococcal infection results in contamination of bedding with Cryptococcus neoformans Contemporary Topics in Laboratory Animal Science 42(4): 9-12
Harris, J.R.; Lindsley, M.D.; Henchaichon, S.; Poonwan, N.; Naorat, S.; Prapasiri, P.; Chantra, S.; Ruamcharoen, F.; Chang, L.S.; Chittaganpitch, M.; Mehta, N.; Peruski, L.; Maloney, S.A.; Park, B.J.; Baggett, H.C. 2012: High prevalence of cryptococcal infection among HIV-infected patients hospitalized with pneumonia in Thailand Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 54(5): E43-E50
Pongmekin, P.; Chongtrakool, P.; Santanirand, P.; Kiertiburanakul, S. 2014: Clinical characteristics and mortality risk factors of cryptococcal infection among HIV-negative patients Journal of the Medical Association of Thailand 97(1): 36-43
Lee, Y.-C.; Wang, J.-T.; Sun, H.-Y.; Chen, Y.-C. 2011: Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection Journal of Microbiology Immunology and Infection 44(5): 338-345
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Mfinanga, S.; Chanda, D.; Kivuyo, S.L.; Guinness, L.; Bottomley, C.; Simms, V.; Chijoka, C.; Masasi, A.; Kimaro, G.; Ngowi, B.; Kahwa, A.; Mwaba, P.; Harrison, T.S.; Egwaga, S.; Jaffar, S.; Chale, P.; Kigocha, O.'o.; Shirima, R.P.; Lema, Y.; Kasubi, M.; Mathania, M.; Makuchilo, M.; Mziray, F.; Alway, C.; Rwezaura, L.; Mgohamwenda, J.; Minde, J.; Luhimbo, T.; Biseko, M.; Kapesa, E.; Shoo, W.; Barankena, A.; Mzyece, J.; Chanda, R.; Salim, E.; Kashongore, G.; Kapotwe, V.; Manan, D. 2015: Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial Lancet 385(9983): 2173-2182
Barsanti, J.A.; Caudle, A.B.; Crowell, W.A.; Shotts, E.B.; Brown, J. 1986: Effect of induced prostatic infection on semen quality in the dog American Journal of Veterinary Research 47(4): 709-712
Bozzette, S.A.; Larsen, R.A.; Chiu, J.; Leal, M.A.; Tilles, J.G.; Richman, D.D.; Leedom, J.M.; McCutchan, J.A. 1991: Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS Annals of Internal Medicine 115(4): 285-286
Andabekov, T.T.; Klochkova, T.G.; Urbanskiĭ, A.I.; Samsonov, R.B.; Shkol'nik, M.I.; Evtushenko, V.I.; Karelin, M.I. 2009: Poorly differentiated prostate cancer may be associated with cytomegalovirus infection in prostatic tissue Voprosy Onkologii 55(2): 183-186
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Cecchi, M.; Sepich, C.A.; Pagni, G.L.; Summonti, D.; Ippolito, C.; Di Benedetto, A.; Bertolini, L.; Minervini, R.; Fiorentini, L. 1998: Prostatic endoprosthesis in the treatment of prostatic obstruction: preliminary experience with the new Trestle model Chirurgia Italiana 50(1): 37-40
Vieillefond, A.; Berger, N.; Dauge-Geffroy, M.C.; Saint Andre, J.P. 1993: Prostatic adenosis and dysplasia. what is their definition... and their significance? Are there "precancerous" lesions in prostatic pathology? Annales de Pathologie 13(2): 85-87
Svanholm, H.; Hørder, M. 1988: Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques Scandinavian Journal of Urology and Nephrology. Supplementum 107: 65-70
Sáenz de Chirife, A.M.; Bassi, A.M.; Celeste, F.; Bergdolt, D. 1991: Specific prostatic antigen in prostatic carcinoma: its relationship with tumor differentiation and clinical course Archivos Espanoles de Urologia 44(4): 405-409
Bouffioux, C. 1983: Prostatic cytology. Value of the technic in the diagnosis and surveillance of prostatic carcinomas; viewpoint of the urologist Acta Urologica Belgica 51(1): 56-71